Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoping Su

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
NPJ Precision Oncology|May 9, 2025
Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinomaXiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, et al.
Blood Neoplasia|August 4, 2025
PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AMLKotoko Yamatani, Tatsuro Watanabe, Kaori Saito, et al.
Scientific Reports|August 19, 2017
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinomaRonan Flippot, Roger Mouawad, Jean-Philippe Spano, et al.
Cancer Research|March 23, 2022
Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In VivoShunbin Xiong, Dhruv Chachad, Yun Zhang, et al.
International Journal of Biological Macromolecules|April 12, 2024
Nucleus-targeting DNase I self-assembly delivery system guided by pirarubicin for programmed multi-drugs release and combined anticancer therapyXuan He, Dan Liang, Jun Zhou, et al.
European Urology Oncology|August 15, 2019
Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder CancerMax Kates, Thomas R Nirschl, Alex S Baras, et al.
The Journal of Clinical Investigation|May 4, 2023
Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasiaHua Wang, Rohan Moniruzzaman, Lei Li, et al.
Nature|August 20, 2015
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6Qian Zhang, Kai Zhao, Qicong Shen, et al.
Blood|May 3, 2013
Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivoAngell Shieh, Ashley F Ward, Kegan L Donlan, et al.
Molecular Oncology|August 16, 2014
Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencingGabriel G Malouf, Jianping Zhang, Ying Yuan, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
NPJ Precision Oncology|May 9, 2025
Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinomaXiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, et al.
Blood Neoplasia|August 4, 2025
PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AMLKotoko Yamatani, Tatsuro Watanabe, Kaori Saito, et al.
Scientific Reports|August 19, 2017
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinomaRonan Flippot, Roger Mouawad, Jean-Philippe Spano, et al.
Cancer Research|March 23, 2022
Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In VivoShunbin Xiong, Dhruv Chachad, Yun Zhang, et al.
International Journal of Biological Macromolecules|April 12, 2024
Nucleus-targeting DNase I self-assembly delivery system guided by pirarubicin for programmed multi-drugs release and combined anticancer therapyXuan He, Dan Liang, Jun Zhou, et al.
European Urology Oncology|August 15, 2019
Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder CancerMax Kates, Thomas R Nirschl, Alex S Baras, et al.
The Journal of Clinical Investigation|May 4, 2023
Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasiaHua Wang, Rohan Moniruzzaman, Lei Li, et al.
Nature|August 20, 2015
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6Qian Zhang, Kai Zhao, Qicong Shen, et al.
Blood|May 3, 2013
Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivoAngell Shieh, Ashley F Ward, Kegan L Donlan, et al.
Molecular Oncology|August 16, 2014
Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencingGabriel G Malouf, Jianping Zhang, Ying Yuan, et al.
Pageof 20